Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01387841
Other study ID # Y010810
Secondary ID
Status Completed
Phase Phase 2
First received July 1, 2011
Last updated July 23, 2013
Start date May 2010
Est. completion date January 2013

Study information

Verified date July 2013
Source Bharath Charitable Cancer Hospital and Institute
Contact n/a
Is FDA regulated No
Health authority India: Institutional Review BoardIndia: Indian Council of Medical Research
Study type Interventional

Clinical Trial Summary

- This randomized controlled three arm study compares the effects of a yoga intervention with jacobsons progressive muscle relaxation training and only standard of care in chemotherapy naive cancer patients.

- This study will also assess the neurophysiological correlates of nausea and vomiting and assess if effects of intervention on nausea and vomiting outcomes are mediated by changes in gastric motility (electrogastrogram) or stress arousal (cardiac autonomic function and sympathetic skin response) or self reported anxiety.


Recruitment information / eligibility

Status Completed
Enrollment 120
Est. completion date January 2013
Est. primary completion date December 2012
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Both
Age group 30 Years to 70 Years
Eligibility Inclusion Criteria:

- Patients with gynecologic malignancies (breast, ovary) and Lymphomas.

- Age between 30-70 years.

- Chemotherapy naïve.

- High school education.

Exclusion Criteria:

- Those with brain metastases

- Concurring medical condition likely to influence survival

- Uncontrolled diabetes and hypertension

- GI metastases, peritoneal fluid, uraemia

- Neurological disorders such as Parkinson's disease, myotonic dystrophy etc.

- GI obstruction and past H/o abdominal surgeries.

- Cognitive impairments.

- Regular participation in a behavioral intervention/yoga in the last six months

Study Design

Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Single Blind (Subject), Primary Purpose: Supportive Care


Related Conditions & MeSH terms


Intervention

Behavioral:
yoga
Postures,relaxation techniques
Jacobsons PMRT group
jacobsons Progressive muscle relaxation training involving 16 muscle groups

Locations

Country Name City State
India Health Care Global Bangalore Karnataka

Sponsors (3)

Lead Sponsor Collaborator
Bharath Charitable Cancer Hospital and Institute Bangalore Institute of Oncology, CENTRAL COUNCIL FOR RESEARCH IN YOGA AND NATUROPATHY

Country where clinical trial is conducted

India, 

Outcome

Type Measure Description Time frame Safety issue
Primary Effect of yoga on chemotherapy induced nausea and vomiting This study is to evaluate the effects of yoga intervention vs. Jacobsons progressive muscle relaxation vs. standard of care only on chemotherapy induced nausea and emesis (CINV) outcomes 4 months (prior to every cycle of chemotherapy,for 4 cycles) No
Secondary Quality of life after chemotherapy Here we evaluate the effects of yoga intervention on secondary outcomes such as quality of life and anxiety states 4 months No
See also
  Status Clinical Trial Phase
Recruiting NCT04681911 - Inetetamab Combined With Pyrotinib and Chemotherapy in the Treatment of HER2 Positive Metastatic Breast Cancer Phase 2
Terminated NCT04066790 - Pyrotinib or Trastuzumab Plus Nab-paclitaxel as Neoadjuvant Therapy in HER2-positive Breast Cancer Phase 2
Completed NCT04890327 - Web-based Family History Tool N/A
Completed NCT03591848 - Pilot Study of a Web-based Decision Aid for Young Women With Breast Cancer, During the Proposal for Preservation of Fertility N/A
Recruiting NCT03954197 - Evaluation of Priming Before in Vitro Maturation for Fertility Preservation in Breast Cancer Patients N/A
Terminated NCT02202746 - A Study to Assess the Safety and Efficacy of the VEGFR-FGFR-PDGFR Inhibitor, Lucitanib, Given to Patients With Metastatic Breast Cancer Phase 2
Active, not recruiting NCT01472094 - The Hurria Older PatiEnts (HOPE) With Breast Cancer Study
Completed NCT06049446 - Combining CEM and Magnetic Seed Localization of Non-Palpable Breast Tumors
Withdrawn NCT06057636 - Hypnosis for Pain in Black Women With Advanced Breast Cancer: A Feasibility Study N/A
Recruiting NCT05560334 - A Single-Arm, Open, Exploratory Clinical Study of Pemigatinib in the Treatment of HER2-negative Advanced Breast Cancer Patients With FGFR Alterations Phase 2
Active, not recruiting NCT05501769 - ARV-471 in Combination With Everolimus for the Treatment of Advanced or Metastatic ER+, HER2- Breast Cancer Phase 1
Recruiting NCT04631835 - Phase I Study of the HS-10352 in Patients With Advanced Breast Cancer Phase 1
Completed NCT04307407 - Exercise in Breast Cancer Survivors N/A
Recruiting NCT03544762 - Correlation of 16α-[18F]Fluoro-17β-estradiol PET Imaging With ESR1 Mutation Phase 3
Terminated NCT02482389 - Study of Preoperative Boost Radiotherapy N/A
Enrolling by invitation NCT00068003 - Harvesting Cells for Experimental Cancer Treatments
Completed NCT00226967 - Stress, Diurnal Cortisol, and Breast Cancer Survival
Recruiting NCT06019325 - Rhomboid Intercostal Plane Block on Chronic Pain Incidence and Acute Pain Scores After Mastectomy N/A
Recruiting NCT06037954 - A Study of Mental Health Care in People With Cancer N/A
Recruiting NCT06006390 - CEA Targeting Chimeric Antigen Receptor T Lymphocytes (CAR-T) in the Treatment of CEA Positive Advanced Solid Tumors Phase 1/Phase 2